Clear. 82.5   F New York
AI-Powered News Summarizer
Top Stories

China approves experimental coronavirus vaccine for military use

June 30, 2020. Summarized by summa-bot.

The Chinese government has approved the use of an experimental Covid-19 vaccine for the country's military -- the latest step in a global race to stop the deadly disease caused by the novel coronavirus.

Hong Kong (CNN)The Chinese government has approved the use of an experimental Covid-19 vaccine for the country's military -- the latest step in a global race to stop the deadly disease caused by the novel coronavirus.

The vaccine, known as Ad5-nCoV, was jointly-developed by the Beijing Institute of Biotechnology -- part of the Chinese government's Academy of Military Medical Sciences -- and vaccine company CanSino Biologics.

In a statement to the Hong Kong Stock Exchange on Monday, CanSino announced that China's Central Military Commission had given the vaccine a "military specially-needed drug approval" on June 25.

Neither the Chinese government nor CanSino have said how broadly the vaccine will be distributed, which units were be selected or whether it will be mandatory or voluntary for personnel.

According to a CanSino statement, clinical trials of the new vaccine have shown a "good safety profile" with initial results indicating that Ad5-nCoV had potential to prevent diseases caused by SARS-CoV-2, the coronavirus strain that causes Covid-19.

CanSino had previously announced in May that the Canadian government was allowing human trials of the Ad5-nCoV vaccine.

According to the statement from CanSino, the first and second phases of their Ad5-nCoV vaccine trials have already been completed.

According to the study, almost half of Ad5-nCoV vaccine recipients reported fever, with 44% describing fatigue and 39% reporting a headache.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.

Suggestions